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Introduction
Information technology is sweeping the healthcare
industry, with all sectors of the industry actively im-
plementing new technology or pursuing ways to use
existing technology more eﬀectively. The past few
years have been ripe with state and federal initiatives
aimed at expanding and implementing information
technology and using it to address the prevalent issues
related to discrepancies in the quality and cost of
ABSTRACT
Background The 1999 Institute ofMedicine (IOM)
report To Err is Human alerted the healthcare
industry and the public to the lack of consistency
in the delivery of quality care to the US population.
Clinical decision support systems (CDSS) have
become a leading response to this report, and to
the growing demand for the promotion of stan-
dards-based care delivery. The objective of this
paper is to evaluate the recent literature for both
the types and eﬀectiveness of electronic CDSS in the
primary care setting.
Methods An electronic search of the literature was
conducted utilisingMEDLINE (1996–2006), CINAHL
(1982–2006) and all EBM Reviews – Cochrane DSR,
ACP Journal Club, DARE and CCTR. The search
included various combinations of theMeSH search
terms ‘clinical decision support systems’, ‘primary
health care’, ‘ambulatory care’ and ‘practice guide-
lines’ and was limited to articles published from
2000 to 2006. Studies were selected for review if they
involved either non-randomised observational or
randomised controlled trials (RCTs) utilisingCDSS
as a single intervention, were performed in an
ambulatory primary care setting and included quan-
tiﬁable outcome measures.
Results Seventeen studies were included in the
review, including ﬁve non-randomised observational
studies and 12 RCTs. Thirteen studies (76%) found
either positive or variable outcomes related to
CDSS intervention with four studies (24%) show-
ing no signiﬁcant eﬀect.
Conclusion Although there is validation that CDSS
has the potential to produce statistically signiﬁcant
improvement in outcomes, there is much variability
among the types and methods of CDSS implemen-
tation and resulting eﬀectiveness. As CDSS will likely
continue to be at the forefront of the march toward
eﬀective standards-based care, more work needs to
be done to determine eﬀective implementation strat-
egies for the use of CDSS across multiple settings
and patient populations.
Keywords: ambulatory care, clinical decision sup-
port systems, primary health care
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health care. In 1999 the ﬁrst Institute ofMedicine (IOM)
report To Err is Human1 was published and high-
lighted for the ﬁrst time widespread inconsistencies
throughout the healthcare industry related to medi-
cation errors and adverse drug events.More recently, a
highly publicised RAND study found that patients
consistently received recommended care only 55% of
the time, regardless of the size or experience of the
clinical setting.2
Nine years after the release of the ﬁrst IOM report,
and ﬁve years after the aforementioned RAND study,
quality issues still abound within the healthcare in-
dustry. Clinical decision support systems (CDSS) have
been touted as a viable solution to these pressing
concerns. Owing to the fact that themajority of health
care delivery takes place in the outpatient setting, the
use of CDSS in this setting is pertinent. This review
seeks to evaluate the recent progress of CDSS as an
eﬀective tool for promoting quality outcomes in the
ambulatory/primary care setting.
Methods
Study identiﬁcation and selection
CDSS has been deﬁned as ‘an automated process for
comparing patient-speciﬁc characteristics against a
computerised knowledge base with resulting recom-
mendations or reminders presented to the provider at
the time of clinical decision making’.3 Although fairly
speciﬁc in deﬁnition, the implementation of CDSS
varies greatly. The three primary components of CDSS
that are identiﬁable in almost all implementations and
that render CDSS diﬀerent from other types of de-
cision support include:
. an automated process for delivery of alerts or
reminders
. patient-speciﬁc content resulting from the com-
parison of patient information against a set of
knowledge ‘rules’ or guidelines
. delivery of alerts or reminders at the point of care.
This search focused on CDSS studies used speciﬁcally
in the primary care, outpatient clinic setting. An elec-
tronic search of the literature was conducted utilising
MEDLINE (1996–2006), CINAHL (1982–2006) and
all EBM Reviews – Cochrane DSR, ACP Journal Club,
DARE and CCTR (up to 2006). Included in the search
strategy were MeSH search terms ‘clinical decision
support systems’, ‘primary health care’, ‘ambulatory
care’, ‘practice guidelines’ and combinations thereof,
to produce an initial retrieval of 274 citations. A title
and abstract review narrowed the search to the 17
studies selected.
Articles selected for ﬁnal review met the following
inclusion criteria:
. English language studies published from 2000 to
2006
. RCTs or non-randomised observational trials
. Ambulatory, out-patient settings utilising only pri-
mary care providers
. Use of at least one comparable control group
. Use of quantiﬁable outcome measures.
Primary reasons for exclusion were that studies were
performed in the in-patient setting or were published
prior to 2000. The authors selected 2000–2006 as a
publication range since rapid changes in both the
healthcare environment and in healthcare informa-
tion technology are quickly making older studies less
noteworthy.
Study evaluation
The 17 studies included in the ﬁnal review were
independently reviewed, with scoring diﬀerences com-
pared for ﬁnal decision. RCTs were evaluated using a
100-point evaluation tool that has been cited in the
literature and used previously for similar reviews.4–6
Non-randomised, controlled or observational studies
were assessed using a 10-point rating scale that has also
been cited in similar reviews of CDSS in the literature
and is designed to accommodate evaluation of non-
randomised trials.3,7,8 Minimum scoring require-
ments for inclusion in the ﬁnal review were set at 50
for RCT’s and ﬁve for non-randomised or obser-
vational trials.
Results
Of the 17 studies9–25 included in this review, 12 studies
utilised an RCT design and ﬁve studies were non-
randomised controlled or observational (Table 1).
Selected studies utilised CDSS for a variety of pur-
poses, including prevention/screening (2), drug dosing
(2), medical management of acute diagnoses (4) and
chronic disease management (11). One study utilised
prevention/screening, medical management and disease
management, and is therefore included in all three
categories.11 The majority of the studies reviewed
(67%) utilisedCDSS for chronic diseasemanagement.
This is in contrast to ﬁndings published prior to 2000,
which routinely found CDSS used most often for
prevention/screening and drug dosing. Additionally,
three recent systematic reviews of CDSS3,6,7 cited the
percentage of studies using CDSS for chronic disease
management as less than 25% of those reviewed.
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Table 1 Characteristics of studies reviewed
Author(s) Pub date Study design CDSS category Automated
prompt
Embed vs
stand alone
Setting Funding Country
Feldstein et al 2006 RCT Disease
Management
Yes Embed Community PharmCo USA
Smith et al 2006 Observational Drug Dosing Yes Embed Community Government USA
Apkon et al 2005 RCT Disease
Management Med
Management
Prevention
Yes Embed VA Government USA
Bassa et al 2005 Observational Disease
Management
No Embed Community PharmCo Spain
Bloomﬁeld et al 2005 Observational Disease
Management
Yes Embed VA Government USA
Samore et al 2005 RCT-cluster Medical
Management
No Stand-
alone
VA Government USA
Sequist et al 2005 RCT-cluster Disease
Management
Yes Embed Academic Government USA
Steele et al 2005 NRCT Prevention Yes Embed Community Government USA
Tierney et al 2005 RCT-cluster Disease
Management
Yes Embed Academic Government USA
McMullin et al 2004 NRCT Drug Dosing Yes Embed Community Vendor USA
Filippi et al 2003 RCT Disease
Management
Yes Embed Community Unknown Italy
Meigs et al 2003 RCT-cluster Disease
Management
No Stand-
alone
Academic Mixed USA
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Table 1 Continued
Author(s) Pub date Study design CDSS category Automated
prompt
Embed vs
stand alone
Setting Funding Country
Tierney et al 2003 RCT-cluster Disease
Management
Yes Embed Academic Government USA
Rollman et al 2002 RCT-cluster Disease
Management
Yes
(simulated)
Embed Academic Government USA
Christakis et al 2001 RCT Disease
Management
Yes Embed Academic NonProﬁt USA
McCowan et al 2001 RCT-cluster Disease
Management
No Stand-alone Community PharmCo UK
Montgomery et al 2000 RCT-cluster Disease
Management
Yes Embed Community Government UK
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Studies included in this review were more likely to
be embedded in an existing electronic medical record
(EMR; 82%) than used as a stand-alone system, and to
be utilised with automated prompt functionality
(76%) rather than requiring provider action for acti-
vation. Thirteen of the studies reviewed were conduc-
ted in the USA (76%), with studies also conducted in
theUnited Kingdom (2), Italy (1) and Spain (1). Studies
which received governmental funding exclusively (US
and UK) accounted for 53% of the studies reviewed,
with the remainder funded by a pharmaceutical com-
pany (partial and full funding; 24%), a software vendor
(6%), another not-for-proﬁt entity (6%) or an un-
known funder (6%). Six of the studies were performed
in university aﬃliated clinics (35%), three at Veterans’
Aﬀairs (VA) facilities (18%) and eight in community
based practices (47%), including two health main-
tenance organisation (HMO) practices.
RCTs
Study descriptions
RCT studies that met the criteria for this review (see
Table 2) were overwhelmingly centered on disease
management, with 75% of the studies implementing
CDSS around chronic diseasemanagement initiatives.
CDSS for disease management targeted cardiovascular
disease (4),11,15,21,25 diabetes (3),15,19,20 asthma (2),17,24
and osteoporosis (1).9 (For clariﬁcation, Sequist et al
addressed both diabetes and coronary artery disease
management, and their study is therefore included on
both counts.) The remaining three RCT studies
addressed medical management of acute disease, in-
cluding depression (1),22 upper respiratory infections
(1)14 and otitis media (1).23
There were 1573 providers and 40 326 patients
represented in the studies reviewed. One study24
required an estimation of providers based on the data
provided. Since CDSS is primarily focused on altering
provider behaviour, the unit of randomisation inmost
CDSS studies was the provider. Randomisation at the
patient level was sometimes utilised, but since ran-
domisation is never blinded in these studies there is
always the potential for contamination if a single
provider is caring for both intervention and control
patients. Often, to avoid contamination, cluster ran-
domisation was used. Nine of the studies reviewed
were randomised at the provider, practice or com-
munity level, while eight used cluster randomisation
either between clinics or groups of providers that work
closely together. Only two studies were randomised at
the patient level.9,11
Study outcomes
One of the challenges in conducting a review of CDSS
studies is the variability not only of the CDSS inter-
ventions studied, but also the variability in primary
outcomes. Primary outcomes often included multiple
endpoints measuring both provider and patient out-
comes. Provider outcomes (e.g. ordering frequency of
procedures or lab tests, prescribing appropriate medi-
cations, adding diagnoses) were more common with
83% of the studies using these either exclusively or in
combinationwith patient outcomes. Patient outcomes
(e.g. speciﬁc lab or result values, cardiovascular risk
factors, patient initiated encounters) were used less
frequently since they are not as easily measured, rely
on patient compliance and generally require longer
periods of assessment. Although only four studies re-
viewed used patient outcome measures (with one study
using these exclusively22) almost all of the studies
reviewed or discussed the need for more research
utilising patient outcomes to better assess the long-
range eﬀectiveness of CDSS.
The use of multiple primary outcomes in most
studies required that ﬁndings be categorised as positive
(all primary outcomes have positive ﬁndings), neutral
(no statistically signiﬁcant diﬀerence found in any
primary outcomes) or variable (combination of both
positive and neutral ﬁndings for primary outcomes).
There were no studies that demonstrated a negative
ﬁnding (patient harm or deterioration related to the
intervention). Of the 12 RCTs reviewed, the results
were split equally with four studies ﬁnding deﬁnitive
positive primary outcomes,9,14,19,23 four with variabil-
ity in primary outcomes,11,15,20,24 and four with neutral
ﬁndings in primary outcomes.17,21,22,25
Studies with neutral ﬁndings had several limitations
that make these ﬁndings less emphatic and worth
noting. For example, Montgomery et al25 utilised a
CDSS with limited interventional capacity (identiﬁ-
cation of cardiovascular risk factors) and yet had
aggressive patient outcome goals (reduction in car-
diovascular risk). Two studies allowed for the CDSS
intervention to be easily sidestepped and ignored,17,21
while a fourth study used CDSS for depression diag-
nosis and management, which has long been recog-
nised as a diagnosis often avoided by primary care
physicians.22
Studies with variable ﬁndings tended to have a large
number of primary outcomes that were reported
either separately11,20 or vaguely.24 By including more
than one or two primary measures, there were often
positive ﬁndings oﬀset by neutral ﬁndings, making
it diﬃcult to determine overall eﬀectiveness of the
CDSS. One study15 reported inconsistencies in the
same outcome, annual cholesterol exam, for patients
with diabetes (P<0.001) and patients with coronary
artery disease (P=0.92), a disease in which cholesterol
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Table 2 RCT study description and results
Author(s) Pub
date
Study
design
Score CDSS Pts/Enc Providers Indication Outcome
allocation
Primary outcome(s) Improvement
in primary
outcome
Apkon
et al
2005 RCT 89 Multiple
Types
1902 12 Preventive
Care, Medical
Management,
Disease
Management
Combination Compliance with 24
measures
12 measures for prevention/
screening; 12 measures for
acute/chronic disease
management
Variable
Christakis
et al
2001 RCT 80 Medical
Management
1339 38 Otitis Media Provider Prescriptions for antibiotic
therapy < 10 day duration
Yes
Feldstein
et al
2006 RCT 87 Disease
Management
311 159 Osteoporosis
Post-fracture
Provider Bone densometry or
osteoporosis medication
prescribed
Yes
Filippi et al 2003 RCT 88 Disease
Management
15343 300 Diabetic
patients > 30
years with at
least 1 CVD
Risk Factor
Provider Anti-platelet therapy
prescribed
Yes
McCowan
et al
2001 RCT-
cluster
52 Disease
Management
477 17 Asthma Combination Compliance with clinical
outcome criteria for asthma
Patient initiated consults,
practice initiated reviews,
acute exacerbations, #
hospitalizations, symptoms
on assessment, medication
use
Variable
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Table 2 Continued
Meigs et al 2003 RCT-
cluster
83 Disease
Management
1098 66 Diabetes Combination 8 measures for Diabetes
mgmt
Frequency: HbA1c, LDL,,
blood pressure, eye exam,
foot exam; Therapy goals:
HbA1c, LDL, systolic/
diastolic blood pressure
Variable
Montgomery
et al
2000 RCT-
cluster
81 Disease
Management
614 85 Hypertension Patient Patients with 5 year CHD >/
= 10%
No
Rollman et al 2002 RCT-
cluster
84 Medical
Management
200 17 Depression Patient HRS-D scores (indication of
depression recovery) at 3
and 6 months
No
Samore et al 2005 RCT-
cluster
83 Medical
Management
13081 176 Acute
Respiratory
Infection
Provider Antimicrobial use for
common acute respiratory
infections
Yes
Sequist et al 2005 RCT-
cluster
81 Disease
Management
4549 194 Coronary
Artery Disease
(CAD),
Diabetes
Provider Compliance with summary
reminders for diabetes and
CAD
Diabetes: Frequency of
cholesterol panel, HbA1c,
eye exam; Meds: ACE
inhibitor with hypertension,
Lipid lowering therapy for
LDL > 130
CAD: Frequency of
cholesterol panel; Meds:
aspirin, beta-blocker, lipid
lowering therapy for LDL >
130
Variable
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Table 2 Continued
Author(s) Pub
date
Study
design
Score CDSS Pts/Enc Providers Indication Outcome
allocation
Primary outcome(s) Improvement
in primary
outcome
Tierney et al 2003 RCT-
cluster
77 Disease
Management
706 201 Heart Failure,
Ischemic
Heart Disease
Provider Compliance with treatment
criteria
Meds: ACE inhibitor, Beta-
blocker, aspirin, diuretic,
long-acting nitrate, anti-
hyperlipidemia medication,
calcium blocker;
Vaccination: pneumococcal
No
Tierney et al 2005 RCT-
cluster
72 Disease
Management
706 274 Asthma,
COPD
Provider Compliance with treatment
criteria
Vaccination: ﬂu,
pneumococcal; Freq:
pulmonary function test;
Medications: ipratorpium,
inhaled beta-agonist,
theophylline, inhaled
corticosteroid, oral
corticosteroid
No
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measurement is generally considered routine manage-
ment. A meta-analysis by Balas et al6 further validated
such unpredictability in outcomes in a review of 33
studies utilising CDSS for prevention and screening.6
Despite an overall increase in improvement of 13.1%
(95% CI), there was marked variability in outcomes
related to speciﬁc endpoints, from 5.7% improvement
in documentation of pap smears to 18.3% for inﬂu-
enza vaccination.
The RCT studies showing deﬁnitive positive ﬁndings
were generally well-designed studies with a single,
quantiﬁable primary outcome that was targeted
toward provider adherence to CDSS. Primary out-
come measures in these studies included ordering of
procedures (bone densometry) and prescribing medi-
cation therapy (anti-platelet, antimicrobial and osteo-
porosis therapy). These studies were straightforward,
targeted studies that did not attempt to capture data
on multiple diseases or interventions.
All of the RCTs reviewed acknowledged limitations
of generalisability related to the patient population
studied. Additionally, limitations cited included small
sample size or a poorly designed study,24 possible
contamination of control groups,11,22 inconsistent
use of CDSS by randomised providers,17,19–21 selec-
tion bias based on EMR usage/proﬁciency25 and con-
founding factors without statistical control.23
Observational non-randomised trials
Study descriptions
The types of CDSS interventions seen in the non-
randomisedandobservational studiesweremore equally
distributed between disease management (40%), drug
dosing/prescribing patterns (40%) and prevention/
screening (20%). Although fewer studies were in-
cluded in this group, publication dates for all ﬁve
studies were between 2004 and 2006, indicating recent
work with all ﬁve studies reporting data collection no
more than four years prior to publication (see Table 3).
Although these studies were all conducted in com-
munity practice settings instead of academic settings,
60% received government fundingwith the remaining
40% coming from software vendor and pharmaceutical
companies.
This group of studies included over 459 000 patients
andover 339 providers. The large patient sample size is
misleading as one study10 was conducted using an
HMO patient population of 450 000 patients with a
primary outcome of prescriptions generated/10 000
members/month. Owing to the calculation of the
outcome measure, there was no need to determine
the exact number of patients for which the CDSS was
applicable, and therefore this number was not reported.
A second study12 conducted at a single site practice
with over 400 patients did not include the exact
number of providers involved, and thus the number
of providers was estimated based on data provided.
Study outcomes
The ﬁndings in all ﬁve studies in this group (100%)
showed statistically signiﬁcant improvement in pri-
mary outcomes related to use of CDSS. CDSS inter-
ventions varied in this group of studies, just as with
RCT studies; however, the primary outcomes in all but
one study were aimed at providers and included a
single primary outcome measure. This removed the
issue of variable ﬁndings and facilitated study inter-
pretation and review. Primary outcomes in this group
included medication prescribing patterns (3),10,13,18
screening for latent tuberculosis infection (LTBI) (1)16
and achievement of therapy treatment goals (summary
cholesterol results) for hypercholesterolemia (1).12 As
expected, all ﬁve studies reported limitations related
to non-randomised study design with little or no
adjustments for baseline diﬀerences between measure-
ment groups. In addition, generalisability issues due
to patient population characteristics were discussed
and at least two of the studies contained selection bias
with study inclusion related to EMR system use by
providers.12,18
Discussion
The authors reviewed 17 studies of CDSS intervention
in the primary care/ambulatory setting. Although this
is a small review, the concentration on recent publi-
cations oﬀers insight into current and future trends
in this highly visible and rapidly developing area of
study. This review reinforced previous work by show-
ing positive correlation between the use of CDSS in the
ambulatory setting and improved outcomes.5 Overall,
76% of the studies reviewed had either partial or com-
plete improvement in outcomes documented. Nine of
the studies found deﬁnitive positive outcomes, with an
additional group of four studies showing improve-
ment for some of the outcomes measured.
There are several factors worth noting as a result of
this review. First, more research is certainly needed
involving the eﬀectiveness of CDSS on patient out-
comes in order to adequately understand the useful-
ness of CDSS in the clinical setting. Since clinical
decision support has a primary function aimed at
providing information to the provider at the point
of care for decision making and intervention, out-
comes which measure process or provider behaviour
are often used as a proxy for patient outcomes. Garg7
and colleagues support this position based on the
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Table 3 Non-randomised, observational study descriptions and results
Author(s) Pub
date
Study
design
Score CDSS Pts/Enc Providers Indication Outcome
allocation
Primary outcome(s)
Improvement in primary outcome
Bassa et al 2005 Prospective,
before/after
6 Disease
Management
404 Unknown Hyper-
cholester-
olemia
Patient Achievement of therapy goals
Cholesterol, LDL, HDL
Yes
Bloomﬁeld
et al
2005 Prospective,
before/after
6 Disease
Management
9015 92 Ischemic
heart
disease with
low HDL
Provider Lipid lowering medication therapy Yes
McMullin
et al
2004 Retro-
spective
cohort
7 Drug
Dosing
6254 38 New
prescriptions
Provider Prescription costs Yes
Smith et al 2006 Prospective,
observa-
tional
7 Drug
Dosing
450000 209 Elderly
patients
Provider Prescriptions/10 000 member per
month for two drug classes
contraindicated for elderly patients
Certain benzodiazepines, tricyclic
antidepressants
Yes
Steele et al 2005 Prospective
NRCT
6 Preventive/
Screening
249 Unknown Latent
tuberculosis
infection
(LTBI)
Provider Adherence to LTBI screening criteria Yes
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small patient populations in most CDSS research to
date, but clearly state that further research targeting the
eﬀect on patient outcomes is needed. Donabedian26
discussed the necessity of determining the eﬀect of any
intervention on patient outcomes as the ultimate goal,
but suggested that a relationship exists between pro-
cess and outcomes. Additionally, the relatively short
study periods for the studies reviewedmake it diﬃcult
to ascertain the long-term eﬀect on patient outcomes
from the current body of knowledge. The authors
support the assertion that the impact of CDSS on
patient outcomes needs further study, but that analysis
of process outcomes has merit as an interim platform
to justify the continuing role of CDSS in clinical care.
Second, there is wide variation and interpretation
in CDSS implementation, and most studies can truly
speak only to the eﬀectiveness of a particular CDSS
product used in a particular setting. Diﬀerences in
system requirements and clinician interaction vary
greatly between studies. For instance, one system may
require that users respond to every CDSS prompt in
acknowledgement of the content whereas other sys-
tems allow easy avoidance of all prompts. Some
research studies were excluded from this review where
the primary endpoints measured were subjective
(patient-reported) measures of improvement,27 if
the intervention mixed computer-generated CDSS
with non-electronic forms of decision support28 or if
a decision-support intervention was utilised that was
not in real time or not delivered at the point of care.29
Until variations such as these are controlled, it is
diﬃcult to assess generalisability of any given CDSS
system.
Third, CDSS systems are evolving rapidly and
maturing quickly, as is physician acceptance of the
use of practice guidelines in the routine provision of
care. To determine the eﬀectiveness or usability of
CDSS interventions based on research performed even
ﬁve to ten years ago is biased and misleading. Add-
itionally, the predominance of CDSS interventions
which have been developed within academic settings
limits generalisability to other settings, most particu-
larly the community based practice setting.30 Signiﬁ-
cant change in the mindset of providers related to
practising evidence-based medicine is likewise evolv-
ing. As recently as four or ﬁve years ago, there was
frequent discussion of the diﬃculties involved with
physician acceptance of guideline-based care algor-
ithms.17,31 In a 1999 publication by Cabana et al,32 the
authors reported on the myriad of barriers to guide-
line acceptance, ranging from a lack of knowledge to
the inertia of routine practice patterns. By 2003, research
by Bates and colleagues33 had progressed to the point
of addressing speciﬁc criteria needed for guideline
acceptance as it relates to CDSS, including CDSS-
supported guideline concordance and the identiﬁcation
of recommended actions which are patient speciﬁc,
timely and user-friendly. Improvements in CDSS
tools, a heightened awareness of the inconsistency in
quality care and the rapid progression toward per-
formance-based reimbursement, have helped facili-
tate changes in the mindsets of physicians to be more
accepting of both clinical guidelines and the systems
which promote their use.
The fourth factor of note is the urgent need formore
research in the ambulatory/primary care setting to
evaluate the use and eﬀectiveness of CDSS in this
environment and to determine successful implemen-
tation strategies. RCTs, especially related to the man-
agement of chronic disease, are necessary to gain the
acceptance and attention of the industry. Likewise,
multi-site, multi-application trials across varied prac-
tice settings are needed to enable generalisability of the
concept of CDSS. Clearly a limitation of this study is
the decision by the authors to include observational,
non-controlled trials in this review. Garg et al7 com-
ment on the frequency of such trials in the literature as
well as the challenges and limitations faced in analysing
the positive eﬀect of CDSS due to the wide variation in
outcome measures, even among RCTs. These issues
are consistent in our work, as are variations in the
randomisation unit (cluster versus patient versus pro-
vider). Although the observational trials strengthened
the case for an overall positive eﬀect of CDSS on
improved outcomes (71%), excluding these studies
would still have resulted in the same conclusions
(67%) in this review. Furthermore, the inclusion of
the studies provided a broader range of discussion of
the current body of knowledge surrounding CDSS.
Recent publications are attempting to address this
need partially through the determination of CDSS
features that correlate with improved outcomes.8,33
The study by Kawamoto8 identiﬁed four features that,
when all were present in a CDSS application, corre-
lated with 94% improvement in outcomes. Likewise,
Bates33 reported on the ‘ten commandments’ for eﬀect-
ive clinical decision support, citing workﬂow eﬃ-
ciency and highly directive prompts as two primary
factors necessary for wide-scale adoption of CDSS.
Research in this area must also focus on the use of the
highly complex systems necessary for the chronic
disease management that is largely dealt with in the
ambulatory/primary care setting.
In a recent editorial, Sidorov postulates that electronic
health records have been insuﬃcient in decreasing
errors and reducing the cost of health care.34 Chaudhry
provides a counterbalance to that view by stating that
‘[CDSS and] health information technologies are
tools that support the delivery of care – they do not,
in and of themselves, alter states of disease or of
health’.30 In June 2006, the AmericanMedical Inform-
atics Association (AMIA) announced their ‘Roadmap
for National Action on Clinical Decision Support’,
giving further validation to the value of CDSS in the
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current industry.35 The comments of Sidorov remind
us that EMRs andCDSSs have not proven to date to be
the ‘magic pill’ for an ailing healthcare system. How-
ever, one must also consider CDSS for what it is – a
tool that, along with an EMR, can augment the
delivery of care in much the same way as a laboratory
test does – by providing additional information about
the patient’s state of health from which the provider
can make a more educated and informed decision. It
involvesmuchmore than just the implementation of a
software application. It requires adaptation by clin-
icians to use and engage in the reﬁnement of CDSS
both as a process and as a tool, as we move toward the
goal of healthcare delivery that is consistent, eﬀective,
eﬃcient and of high quality.
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